The physician's Alzheimer's disease management guide: Early detection and diagnosis of cognitive impairment, Alzheimer's disease and related dementia

por Reiss, Allison B., de Levante Raphael, Donna, Chin, Nathaniel A., Sinha, Vivek
Publicado 2022

Disclosure of preclinical Alzheimer's disease biomarker results in research and clinical settings: Why, how, and what we still need to know

por Erickson, Claire M., Chin, Nathaniel A., Johnson, Sterling C., Gleason, Carey E., Clark, Lindsay R.
Publicado 2021

Feasibility of virtual Alzheimer's biomarker disclosure: Findings from an observational cohort

por Erickson, Claire M., Chin, Nathaniel A., Rosario, Hannah L., Peterson, Amanda, Johnson, Sterling C., Clark, Lindsay R.
Publicado 2023

The importance of the dyad: Participant perspectives on sharing biomarker results in Alzheimer's disease research

por Ketchum, Fred B., Chin, Nathaniel A., Erickson, Claire, Lambrou, Nickolas H., Basche, Kristin, Gleason, Carey E., Clark, Lindsay
Publicado 2023

Comparing emergency department use among individuals with varying levels of cognitive impairment

por Green, Rebecca K., Shah, Manish N., Clark, Lindsay R., Batt, Robert J., Chin, Nathaniel A., Patterson, Brian W.
Publicado 2022

Implications of preclinical Alzheimer's disease biomarker disclosure for US policy and society

por Erickson, Claire M., Clark, Lindsay R., Ketchum, Fred B., Chin, Nathaniel A., Gleason, Carey E., Largent, Emily A.
Publicado 2022

Predictors of Willingness to Enroll in Hypothetical Alzheimer Disease Biomarker Studies that Disclose Personal Results

por Erickson, Claire M., Chin, Nathaniel A., Ketchum, Frederick B., Jonaitis, Erin M., Zuelsdorff, Megan L., Gleason, Carey E., Clark, Lindsay R.
Publicado 2022

What Influences the Willingness of Blacks and African Americans to Enroll in Preclinical Alzheimer’s Disease Biomarker Research? A Qualitative Vignette Analysis

por Ketchum, Fred B., Erickson, Claire M., Chin, Nathaniel A., Gleason, Carey E., Lambrou, Nickolas H., Benton, Susan Flowers, Clark, Lindsay R.
Publicado 2022

The relationship of insulin resistance and diabetes to tau PET SUVR in middle-aged to older adults

por Ennis, Gilda E., Betthauser, Tobey J., Koscik, Rebecca Langhough, Chin, Nathaniel A., Christian, Bradley T., Asthana, Sanjay, Johnson, Sterling C., Bendlin, Barbara B.
Publicado 2023

Virtual disclosure of preclinical Alzheimer's biomarkers: Preliminary experiences

por Erickson, Claire M., Chin, Nathaniel A., Coughlin, DaRae M., Conway, Camille E., Rosario, Hannah L., Johnson, Sterling C., Clark, Lindsay R.
Publicado 2021

Anticipated reactions to learning Alzheimer’s disease biomarker results

por Clark, Lindsay R., Erickson, Claire M., Jonaitis, Erin M., Ma, Yue, Chin, Nathaniel A., Basche, Kristin, Ketchum, Frederick B., Gleason, Carey E.
Publicado 2022

Moving beyond disclosure: Stages of care in preclinical Alzheimer's disease biomarker testing

por Ketchum, Fred B., Chin, Nathaniel A., Grill, Joshua, Gleason, Carey E., Erickson, Claire, Clark, Lindsay R., Paulsen, Jane S., Kind, Amy J.H.
Publicado 2022

Sympathoexcitatory Responses to Isometric Handgrip Exercise Are Associated With White Matter Hyperintensities in Middle-Aged and Older Adults

por Pearson, Andrew G., Miller, Kathleen B., Corkery, Adam T., Eisenmann, Nicole A., Howery, Anna J., Cody, Karly A., Chin, Nathaniel A., Johnson, Sterling C., Barnes, Jill N.
Publicado 2022

Prescription Medications and Co-Morbidities in Late Middle-Age are Associated with Greater Cognitive Declines: Results from WRAP

por Du, Lianlian, Koscik, Rebecca Langhough, Chin, Nathaniel A., Bratzke, Lisa C., Cody, Karly, Erickson, Claire M., Jonaitis, Erin, Mueller, Kimberly D., Hermann, Bruce P., Johnson, Sterling C.
Publicado 2022

Cardiology clinic patient attitudes toward and potential personal utility of genetic testing: Findings from a unique multiracial clinical sample

por Erickson, Claire M., Clark, Lindsay R., Umucu, Emre, Vo, Nhi H., Volgman, Annabelle Santos, Chin, Nathaniel A., Ketchum, Fred B., Jones, Carolyn H., Gleason, Carey E., Aggarwal, Neelum T.
Publicado 2022

Plasma phosphorylated tau 217 in preclinical Alzheimer’s disease

por Jonaitis, Erin M, Janelidze, Shorena, Cody, Karly A, Langhough, Rebecca, Du, Lianlian, Chin, Nathaniel A, Mattsson-Carlgren, Niklas, Hogan, Kirk J, Christian, Bradley T, Betthauser, Tobey J, Hansson, Oskar, Johnson, Sterling C
Publicado 2023

Cerebrovascular stiffness and flow dynamics in the presence of amyloid and tau biomarkers

por Rivera‐Rivera, Leonardo A., Eisenmenger, Laura, Cody, Karly A., Reher, Thomas, Betthauser, Tobey, Cadman, Robert V., Rowley, Howard A., Carlsson, Cynthia M., Chin, Nathaniel A., Johnson, Sterling C., Johnson, Kevin M.
Publicado 2021

Comparison of different MRI-based morphometric estimates for defining neurodegeneration across the Alzheimer's disease continuum

por Allison, Samantha L., Koscik, Rebecca L., Cary, Robert P., Jonaitis, Erin M., Rowley, Howard A., Chin, Nathaniel A., Zetterberg, Henrik, Blennow, Kaj, Carlsson, Cynthia M., Asthana, Sanjay, Bendlin, Barbara B., Johnson, Sterling C.
Publicado 2019

Trajectory of clinical symptoms in relation to amyloid chronicity

por Birdsill, Alex C., Koscik, Rebecca L., Cody, Karly A., Jonaitis, Erin M., Cadman, Robert V., Erickson, Claire M., Chin, Nathaniel A., Przybelski, Robert J., Carlsson, Cynthia M., Asthana, Sanjay, Christian, Bradley T., Eisenmenger, Laura B., Betthauser, Tobey J., Johnson, Sterling C.
Publicado 2022

Amyloid and tau imaging biomarkers explain cognitive decline from late middle-age

por Betthauser, Tobey J, Koscik, Rebecca L, Jonaitis, Erin M, Allison, Samantha L, Cody, Karly A, Erickson, Claire M, Rowley, Howard A, Stone, Charles K, Mueller, Kimberly D, Clark, Lindsay R, Carlsson, Cynthia M, Chin, Nathaniel A, Asthana, Sanjay, Christian, Bradley T, Johnson, Sterling C
Publicado 2020